Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 6,741.15
-26.00 (-0.38%)
At close: Jun 19, 2026
Divi's Laboratories Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Divi's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹7,059. The average 1-year stock price forecast is 4.72% higher than the current stock price, while the lowest is ₹5,160 (-23.46%) and the highest is ₹9,450 (+40.18%).
Price Target: ₹7,059 (+4.72%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Divi's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 11 | 11 | 11 | 10 | 10 |
| Buy | 5 | 4 | 4 | 4 | 5 | 5 |
| Hold | 5 | 5 | 5 | 6 | 6 | 6 |
| Sell | 6 | 7 | 7 | 8 | 6 | 6 |
| Strong Sell | 6 | 4 | 4 | 2 | 3 | 3 |
| Total | 31 | 31 | 31 | 31 | 30 | 30 |
Financial Forecast
Revenue This Year
122.66B
from 105.60B
Increased by 16.16%
Revenue Next Year
145.16B
from 122.66B
Increased by 18.34%
EPS This Year
114.48
from 98.86
Increased by 15.80%
EPS Next Year
140.93
from 114.48
Increased by 23.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 136.5B | ||
| Avg | 122.7B | ||
| Low | 117.3B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 29.3% | ||
| Avg | 16.2% | ||
| Low | 11.1% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 138.80 | ||
| Avg | 114.48 | ||
| Low | 102.50 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 40.4% | ||
| Avg | 15.8% | ||
| Low | 3.7% |